$4.07
0.246.14%
Ult. Agg.: Oct 20, 10:42 AM
$3.84
0.010.26%
Aquestive Therapeutics (AQST) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Aquestive Therapeutics (AQST) ha pubblicato l'ultima guidance il agosto 11, 2026 per fiscal year 2026. La società ha previsto un fatturato pari a $46M - $50M per il periodo.
Rispetto alle previsioni precedenti, Aquestive Therapeutics ha modificato le sue previsioni di fatturato da un intervallo precedente di .
Aquestive Therapeutics ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Aquestive Therapeutics. 17
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.12 | $-0.13 | $-0.12 | $-0.12 |
| Actual | $-0.18 | $-0.07 | $-0.15 | $-0.14 |
| Surprise | -50.0% | +46.2% | -25.0% | -16.7% |
| Revenue | ||||
| Estimate | $11.7M | $10.9M | $13.3M | $13.1M |
| Actual | $13.8M | $14.4M | $13.0M | $12.8M |
| Surprise | +18.1% | +32.7% | -2.28% | -2.31% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.13 | $-0.13 | $-0.09 | $-0.10 |
| Revenue | ||||
| Consensus | $11.0M | $11.6M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.18 | $-0.12 | -50.0 % |
| Q1 | May 13, 2026 | $-0.07 | $-0.13 | 46.2 % |
| Q4 | Mar 4, 2026 | $-0.15 | $-0.12 | -25.0 % |
| Q3 | Nov 5, 2025 | $-0.14 | $-0.12 | -16.7 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $13.82M | $11.70M | 18.1 % |
| Q1 | May 13, 2026 | $14.45M | $10.88M | 32.7 % |
| Q4 | Mar 4, 2026 | $13.02M | $13.32M | -2.28 % |
| Q3 | Nov 5, 2025 | $12.81M | $13.11M | -2.31 % |